Representativeness in Premarketing vs Postmarketing US Food and Drug Administration Trials
JAMA Netw Open
.
2021 Apr 1;4(4):e217159.
doi: 10.1001/jamanetworkopen.2021.7159.
Author
Joseph M Unger
1
Affiliation
1
Fred Hutchinson Cancer Research Center, Seattle, Washington.
PMID:
33877312
DOI:
10.1001/jamanetworkopen.2021.7159
No abstract available
Publication types
Comment
MeSH terms
Humans
Product Surveillance, Postmarketing*
United States
United States Food and Drug Administration